Amgen pledges to launch Eylea biosim after legal win—but Regeneron stresses the fight’s not over yet
October 23, 2024Roche CEO says Novo’s Catalent buyout ‘could be a problem’ for smaller drugmakers
October 23, 2024Red light, green light: England’s NICE not sold on Lilly’s Kisunla despite UK approval
zbecker
Wed, 10/23/2024 – 11:02
